Tetrahydro-4-aminobiopterin attenuates dendritic cell-induced T cell priming independently from inducible nitric oxide synthase

Journal of Immunology

Volumn 174, Issue 12, 2005, Pages 7584-7591

  Thoeni, Guntram ^a   Stoitzner, Patrizia ^a   Brandacher, Gerald ^a   Romani, Nikolaus ^a   Heufler, Christine ^a   Werner Felmayer, Gabriele ^a   Werner, Ernst R ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; B7 ANTIGEN; B7 H1 ANTIGEN; BIOPTERIN; CD4 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CYTOKINE; ICOS PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIGAND; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; N6 (1 IMINOETHYL)LYSINE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; OVALBUMIN; PROTEIN; PTERIDINE DERIVATIVE; TETRAHYDRO 4 AMINOBIOPTERIN; TETRAHYDROBIOPTERIN; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; ATTENUATION; BONE MARROW DERIVED DENDRITIC CELL; CARDIAC GRAFT REJECTION; CELL FUNCTION; CELL MATURATION; CELL SURVIVAL; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; GENE OVEREXPRESSION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; KNOCKOUT MOUSE; MITOGENESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; PRIORITY JOURNAL; SEPTIC SHOCK; T LYMPHOCYTE ACTIVATION; TH1 CELL;

EID: 20444405032     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.12.7584     Document Type: Article

References (35)

1. Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2: 907-916.
2. Werner, E. R., and G. Werner-Felmayer. 2002. Biopterin analogues: novel nitric oxide synthase inhibitors with immunosuppressive action. Curr. Drug Metab. 3: 119-121.
3. Werner, E. R., A. C. F. Gorren, R. Heller, G. Werner-Felmayer, and B. Mayer. 2003. Tetrahydrobiopterin and nitric oxide: mechanistic and pharmacological aspects. Proc. Soc. Exp. Biol. Med. 228: 1291-1302.
4. Werner, E. R., E. Pitters, K. Schmidt, H. Wachter, G. Werner-Felmayer, and B. Mayer. 1996. Identification of the 4-amino analog of tetrahydrobiopterin as dihydropteridine reductase inhibitor and potent pteridine antagonist of rat enuronal nitric oxide synthase. Biochem. J. 320: 193-196.
5. Mayer, B., C. Q. Wu, A. C. F. Gorren, S. Pfeifer, K. Schmidt, P. Clark, D. J. Stuehr, and E. R. Werner. 1997. Tetrahydrobiopterin binding to macrophage inducible nitric oxide synthase: heme spin shift and dimer stabilization by the potent pterin antagonist 4-amino-tetrahydrobiopteirn. Biochemistry 36: 8422-8427.
6. Schmidt, K., G. Werner-Felmayer, B. Mayer, and E. R. Werner. 1999. Preferential inhibition of inducible nitric oxide synthase in intact cells by the 4-amino-analogue of tetrahydrobiopterin. Eur. J. Biochem. 259: 25-31.
7. Brandacher, G., Y. Zou, P. Obrist, W. Steurer, G. Werner-Felmayer, R. Margreiter, and E. R. Werner. 2001. The 4-amino analogue of tetrahydrobiopterin efficiently prolongs murine cardiac-allograft survival. J. Heart Lung Transplant 20: 747-749.
8. Bahrami, S., F. Fitzal, G. Peichl, H. Gasser, W. Fürst, A. Banerjee, W. Strohmaier, H. Redl, G. Werner-Felmayer, and E. R. Werner. 2000. Protection against endotoxemia in rats by a novel tetrahydrobiopterin analogue. Shock 13: 386-391.
9. Winlaw, D. S., C. G. Schyvens, G. A. Smythe, Z. Y. Du, S. P. Rainer, R. S. Lord, P. M. Spratt, P. S. Macdonald. 1995. Selective inhibition of nitric oxide production during cardiac allograft rejection causes a-small increase in graft survival. Transplantation 60: 77-82.
10. Worall, N. K., W. D. Lazenby, T. P. Misko, T. S. Lin, C. P. Rodi, P. T. Manning, R. G. Tilton, J. R. Williamson, and T. B. Ferguson. 1995. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J. Exp. Med. 181: 63-70.
11. 6-(1-iminoethyl)-L- lysine in acute cardiac transplant rejection. Am. J. Physiol. 286: H525-H534.
12. Mannon, R. B., K. Roberts, P. Ruiz, V. Laubach, and T. M. Coffman. 1999. Inducible nitric oxide synthase promotes cytokine expression in cardiac allografts but is not required for efficient rejection. J. Heart Lung Transplant. 18: 819-827.
13. +/+ mice. Circulation 103: 2514-2520.
14. Koglin, J. 2000. Pathogenetic mechanism of cardia allograft vasculopathy-impact of nitric oxide. Z. Kardiol. 89: IX/24-27.
15. Nichol, C. A., G. K., Smith, and D. S. Duch. 1985. Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin. Annu. Rev. Biochem. 54: 729-764.
16. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol. 76: 34-40.
17. McLellan, A. D., G. Terbeck, T. Mengling, G. C. Starling, P. A. Kiener, R. Gold, E. B. Brocker, M. Leverkus, and E. Kämpgen. 2000. Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development. Cell Death Differ. 7: 933-938.
18. Austyn, J. M., R. M. Steinman, D. E. Weinstein, A. Granelli-Piperno, and M. A. Palladino. 1983. Dendritic cells initiate a two-stage mechanism for T lymphocyte proliferation. J. Exp. Med. 157: 1101-1115.
19. Heller, R., A. Unbehaun, B. Schellenberg, B. Mayer, G. Werner-Felmayer, and E. R. Werner. 2001. L-Ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J. Biol. Chem. 276: 40-47.
20. Thoeni, G., E. R. Werner, and G. Werner-Felmayer. 2004. Tetrahydropteridines suppress gene expression and induce apoptosis of activated RAW264.7 cells via formation of hydrogen peroxide. Free Radic. Biol. Med. 37: 375-385.
21. Werner-Felmayer, G., G. Golderer, and E. R. Werner. 2002. Tetrahydrobiopterin biosynthesis, utilization and pharmacological effects. Curr. Drug Metab. 3: 159-173.
22. Schmidt, H. H., T. D. Warner, M. Nakane, U. Förstermann, and F. Murad. 1992. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Mol. Pharmacol. 41: 615-624.
23. Miles, P. R., L. Bowman, A. Rengasamy, and L. Huffman. 1998. Constitutive nitric oxide production by rat alveolar macrophages. Am. J. Physiol. 274: L360-L368.
24. Connelly, L., A. T. Jacobs, M. Palacios-Callender, S. Moncada, and A. J. Hobbs. 2003. Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression. J. Biol. Chem. 278: 26480-26487.
25. Mayer, B., P. Klatt, E. R. Werner, and K. Schmidt. 1995. Kinetics and mechanism of tetrahydrobiopterin-induced oxidation of nitric oxide. J. Biol. Chem. 270: 655-659.
26. Hoffman, R. A., J. M. Langrehr, K. E. Dull, S. A. McCarthy, M. L. Jordan, and R. L. Simmons. 1994, Macrophage synthesis of nitric oxide in the mouse mixed leucocyte reaction. Transpl. Immunol. 2: 313-320.
27. Bronte, V., P. Serafini, A. Mazzoni, D. M. Segal, and P. Zanovello. 2003. L-Arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol. 24: 302-306.
28. Heufler, C., F. Koch, U. Stanzl, G. Topar, M. Wysocka, G. Trinchieri, A. Enk, R. M. Steinman, N. Romani, and G. Schuler. 1996. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-γ production by T helper 1 cells. Eur. J. Immunol. 26: 659-668.
29. Akbari, O., R. H. DeKruyff, and D. T. Umetsu. 2001. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2: 725-731.
30. Steinbrink, K., M. Wolfl, H. Jonuleit, J. Knop, and A. H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159: 4772-4780.
31. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
32. Pierre, P., S. J. Turley, E. Gatti, M. Hull, J. Meltzer, A. Mirza, K. Inaba, R. M. Steinman, and I. Mellman. 1997. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388: 787-792.
33. Aicher, A., M. Hayden-Ledbetter, W. A. Brady, A. Pezzutto, G. Richter, D. Magaletti, S. Buckwalter, J. A. Ledbetter, and E. A. Clark. 2000. Characterization of human inducible costimulator ligand expression and function. J. Immunol. 164: 4689-4696.
34. Hackstein, H., and A. W. Thomson. 2004. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 4: 24-34.
35. Mellor, A. L., and D. H. Munn. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4: 762-774.